Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CANC

Tema Oncology ETF

Dec 19 • 04:00PM ET

34.88

+0.71 2.07 %

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	34.62%	Total Holdings	54	Perf Week	0.71%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	AUM	109.18M	Perf Month	2.80%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	NAV/sh		Perf Quarter	27.17%
Index	-	Average Maturity		Tags	-	Return% 10Y		52W High	36.14 -3.48%	Perf Half Y	41.28%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	20.10 73.58%	Perf YTD	43.50%
Active/Passive		Quant Type		Tags	-	Flows% 1M	12.15%	Volatility	1.18% 1.93%	Perf Year	36.47%
Dividend TTM	0.02 (0.06%)	ESG Type		Tags	-	Flows% 3M	16.82%	ATR (14)	0.66	Perf 3Y	-
Dividend Ex-Date	Dec 10, 2025	Dividend Type		Sector/Theme		Flows% YTD	47.78%	RSI (14)	58.70	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.99	Perf 10Y	-
Expense	0.75%	Growth/Value		SMA20	-0.01%	Flows% 3Y		Rel Volume	1.06	Prev Close	34.17
Inverse/Leveraged		Market Cap		SMA50	6.75%	Flows% 5Y		Avg Volume	17.34K	Price	34.88
IPO	Aug 16, 2023	Option/Short	No / Yes	SMA200	27.89%	Trades		Volume	18,399	Change	2.07%

Dec-02-25 06:00AM	Temas Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance (Business Wire)
Nov-26-25 10:00AM	Be Thankful to These ETFs This Year (Zacks)
Nov-21-25 08:00AM	Inside the Recent Strength in Biotech ETFs (Zacks)
Oct-20-25 06:00AM	Biotech ETFs Bounce Back in 2025: Here's Why (Zacks)

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your FINVIZ experience